<p>Anthony Baughn of the University of Minnesota in the U.S. will test a library of cyclic peptides to identify small molecules that impair the ability of the tuberculosis- causing bacterium M. tuberculosis to develop resistance to current drug therapies, for use in a new class of tuberculosis antibiotics.</p>


Anthony Baughn of the University of Minnesota in the U.S. will test a library of cyclic peptides to identify small molecules that impair the ability of the tuberculosis- causing bacterium M. tuberculosis to develop resistance to current drug therapies, for use in a new class of tuberculosis antibiotics.